Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fabtech Technologies's revenue for the
three
months ended in Jun. 2026 was ₹750 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₹2,963 Mil.
Fabtech Technologies's Revenue per Share for the
three
months ended in Jun. 2026 was ₹16.92.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹75.49.
During the past 5 years, Fabtech Technologies's highest 3-Year average Revenue per Share Growth Rate was 35.60% per year. The lowest was 8.30% per year. And the median was 21.95% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:FABTECH vs VEEV, BTSG, HQY: Revenue Comparison
For the Health Information Services subindustry, Fabtech Technologies's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabtech Technologies Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fabtech Technologies's Revenue distribution charts can be found below:
* The bar in red indicates where Fabtech Technologies's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,963 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabtech Technologies (NSE:FABTECH) has a Revenue of ₹2,963 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Fabtech Technologies and its competitors.
Is Fabtech Technologies' Revenue too high?
Fabtech Technologies' current Revenue is ₹2,963 Mil. Overall, Fabtech Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Fabtech Technologies' Revenue compare to VEEV and BTSG?
Fabtech Technologies' Revenue of ₹2,963 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Fabtech Technologies and its competitors. Fabtech Technologies's current Revenue is ₹2,963 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabtech Technologies stock overvalued right now?
Fabtech Technologies (NSE:FABTECH) has a current Revenue of ₹2,963 Mil. The current Revenue is ₹2,963 Mil. Fabtech Technologies' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Fabtech Technologies (NSE:FABTECH), the current Revenue is ₹2,963 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
20GF Score
Get the complete analysis for NSE:FABTECH
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FABTECH has been successfully added to your 
